business models

I wonder, have you ever had a conversation with your doctor or nurse about barcodes? Not likely, I guess! Whilst the humble barcode is so ingrained in everyday life (after all, we all scan barcodes at the checkout), its potential in healthcare is both enormous, but unfortunately largely unknown. The reality is that for patients and caregivers, the beep of a scanned barcode has the possibility to help ensure that a patient receives the right medical product at the right time and that caregivers have the benefit of additional surety in their processes. Scanning barcodes can help to minimise errors due to incorrect identification of product or patient and ensure the correct product is in the hospital when the patient needs it. The global, voluntary user community, GS1 Healthcare - which brings together all healthcare supply chain stakeholders, including manufacturers, distributors, healthcare providers, solution providers, regulatory bodies and industry associations - recently produced a video to illustrate the value global standard barcodes add in hospital processes. For every one of us, this is a must-watch - after all, at one point in our lives, we will all be patients. For staff of healthcare product supplier organisations this is even more important. After all, suppliers are applying GS1 barcodes to meet a range of regulatory and trading partner requirements. In turn, these barcodes should be used by all healthcare stakeholders, most importantly, the healthcare provider organisations and staff that are issuing these suppliers’ products to patients. Please take two minutes of your time, open your minds and remember that the use of global standard barcodes in healthcare empowers all of us - patients, healthcare provider staff and healthcare provider organisations. A simple scan can contribute to doctors and nurses being able to focus even more on caring for every one of...
Shouldn’t we be rewarded for healthy behaviour rather than repeatedly punished for being ‘bad’? Fat tax and sugar tax, duty on cigarettes and vodka – everyone can think of a ‘sin tax’ they pay from time to time. These are the penalties we pay for making unhealthy choices. The idea of sin taxes has been gaining ground in recent years. The success of price rises on cigarettes and alcohol in curbing consumption is leading governments to consider what other disease-causing products could be taxed out of existence . In Europe, Denmark were the early movers: they introduced a tax on fatty foods in 2011. It applied to meat, dairy products, oils and certain other foods which contained more than 2.3% of saturated fat. The tax ‘worked’ in that it raised revenue and cut consumption of fatty foods by 4% . However, the policy didn’t last long. It was scrapped within 18 months because the government said the tax was too difficult and expensive to collect. Japan is taking a different route . Instead of hitting shoppers in the pocket to reduce the size of their gut, authorities impose fines on employers and local governments who fail to keep waistlines in check. Other countries, including the UK and Ireland have targeted sugary drinks by proposing a ‘soda tax’ to nudge consumers into making healthier choices. Celebrity chef Jamie Oliver – a campaigner for healthy eating – hailed the move as a victory for children’s health. He was so happy about the new tax that he did a little dance at the end of a TV interview which was captured by BBC! There’s no doubt that taxes can be used to push people into making ‘better’ choices. But what ever happened to incentives for positive change? GPs in the UK get bonuses...
We built the War on Cancer website to give patients and their families a storytelling platform. Now it’s time to add new features and bring the medtech industry and healthcare sector into the community In January 2015, I was living in London with my best friend Fabian Bolin . Fabian was preparing to move to LA to pursue his acting career when he began to feel ill. His leukaemia diagnosis came as a total shock and changed our lives forever. Fabian started blogging about his experience as a cancer patient and gained quite a following. I was helping with some of the administrative and practical issues he faced, and supporting him along his journey. One day, when his story began to make headlines and his inbox was full of encouraging messages of support from total strangers, we started to talk about how this could become something even bigger. That’s when we started War on Cancer . At first, we had a simple idea: we wanted to enable people to share their stories and to experience the love that had helped Fabian during a difficult time. But as the project evolved, we saw an opportunity to do more. The storytelling platform is the cornerstone of the community – it helps people through their recovery process and provides others with insights into the reality of undergoing cancer treatment. Our vision is for a more inclusive community where we invite patients and their loved ones, but also medtech companies and the healthcare industry – everyone who has a part to play in eradicating cancer. The potential is considerable. Not only do we want patients to interact with one another, we envision a community where companies, health professionals and others can also create a profile and engage. Through these channels, companies could create seminars,...
A 2015 report from The Lancet Global Surgery Commission found that nearly one-third of the global burden of disease can be treated surgically and that 5 billion people lack access to safe and affordable surgical care. At Johnson & Johnson, we are looking to improve the standard of care and treatment, accelerating our pace of innovation, training more physicians globally through our surgical institutes and our partnerships - such as with the AO Foundation - to help make a difference for patients. As a global leader in the field of surgery our products are literally stitched into almost every surgical procedure in every market around the world. As the Head of Research and Development for the Johnson & Johnson Medical Devices Companies, I have the privilege of leading a team of more than 3,500 engineers, scientists and clinicians focused on developing and delivering safe and clinically meaningful innovative solutions that address unmet needs. It is through the lens of meaningful innovation and the benefits it brings for patients that we make important decisions about how we advance our portfolio. Recently, we’ve brought all of our Medical Devices R&D into a single organisation so that we can adapt our Medical Device innovation model to better meet the needs of a rapidly changing healthcare environment. We have launched an Innovation Agenda that is clear and actionable to everyone in our organisation. Our Agenda places a premium on innovation that we can deliver. It ensures our teams have the proper funding to support innovation and that we create a culture that rewards prudent risk taking. Most importantly, our Innovation Agenda challenges everyone in our organisation to participate in driving meaningful innovation. Specifically, we are shifting our focus from platforms to solutions so that we address medical needs across the full continuum of disease...
Authors: this article was written by Hans Martens, Martha Emneus , Anders Green and Camilla Sortso . This is the first blog of the series presenting the economic value of being in good health and the broader consideration of cost of disease. Europe’s health systems are struggling to maintain sustainability. One of the major challenges is the exponential increase in the prevalence of chronic diseases and the number of patients in advanced and costly disease stages. A challenge, which is predicted to only increase in the years to come. Chronic diseases make high demands on health systems for continuous, quality care. For patients, chronic diseases are associated with shorter lifetime, reduced quality of life and economic as well as socio-economic burdens on the patients, their caregivers - formal or informal. For society, the burden is excess healthcare, pharmaceuticals, nursing, reduced labour market participation and ability to be socially and economically active and premature mortality. Altogether these costs underpin the major challenge of chronic diseases for our societies – not least in Europe where health is a collective rather than an individualised responsibility. This challenge must be dealt with by the health systems and perhaps by reconsidering where investments should be made in the future as with many of the chronical diseases onset and progression can be prevented if diagnosed early and precisely and if the process is well managed. Among chronic diseases, diabetes mellitus is one of the most burdensome with app. 371 million people diagnosed globally and evidence of rapidly increasing prevalence. In a recent study from Denmark it was estimated that costs of diabetes amounted to 14,349 Euro per person year. Of these, health care costs accounted 17% and pharmaceuticals 4%, while for example loss of productivity amounted to 42%. And this is not the whole story, because...
Never before has there been a more compelling time and a more urgent need to disrupt and transform the way we delivery healthcare to the people of our planet. I am the son of a wonderfully devoted Australian country GP who later became the country surgeon in the Hunter Valley in New South Wales. A father of 8, Dad was seemingly forever on-call and, with the exception of his faithful stethoscope, his scary scalpel and his trusty truck, he had absolutely zero technological assistance. No pager, no mobile phones, no EHR, no teleradiology. He was a truly old school practitioner and a mighty man, dedicated to his calling and adored by his patients. As a young lad, accompanying Dad in his old truck on long journeys late at night on those windy roads between each of the country hospitals (trying so hard to stay awake and keep my promise to Mum to make sure Dad did not fall asleep at the wheel), I knew there had to be a better, faster, safer, more effective and more efficient way of delivering healthcare. When my time came, and I followed proudly in Dad's brave footprints, I quietly committed to change the way the traditional hospital based and doctor dependent healthcare service was delivered. I got my chance years later when I set about exploring the possibility of building a simple tele-radiology system over the old 3K copper telephone system to link small isolated communities distributed over an enormous geographical area. This was not an idea borne without experience, as I had found myself performing obstetric ultrasound scans from the back of a truck in remote parts of Western Australia, in oppressive heat, shortly after completing my degree and qualifying as a radiologist. Working with pregnant mums to be in an aboriginal community,...